Skip to main content
Clinical Trials/ITMCTR2200006702
ITMCTR2200006702
Recruiting
未知

A randomized controlled study of acupuncture in the treatment of diarrhea-predominant irritable bowel syndrome

Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
irritable bowel syndrome
Sponsor
Beijing University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Persons aged 18\-70 years old, regardless of gender;
  • (2\) Those who meet the above diagnostic criteria of IBS\-D Rome IV; have typical symptoms of IBS\-D;
  • (3\) The course of the disease exceeds 6 months;
  • (4\) The total score of the IBS Severity Scale at the baseline period is \=75 points;
  • (5\) Patients with mild or moderate depression or anxiety, that is, those with a GAD\-7 total score of 5\-15, or a PHQ\-9 total score of 5\-15;
  • (6\) Normal cognitive function, good compliance, willing to cooperate with the research, voluntarily participate in this trial and sign the informed consent.
  • Note: Inclusion only if all the above conditions are met.

Exclusion Criteria

  • (1\) Those who meet the diagnostic criteria of IBS\-C, IBS\-M, and IBS\-U Rome IV;
  • (2\) Those who have been diagnosed with organic diseases of the digestive system in the past, such as inflammatory bowel disease, intestinal tuberculosis, intestinal tumors, etc.;
  • (3\) Patients with severe heart, cerebrovascular system, liver, kidney, hematopoietic system, endocrine system, and rheumatic immune system in the past;
  • (4\) Severe mental illness and obvious cognitive impairment in the past;
  • (5\) Patients who have received acupuncture treatment in the past three months;
  • (6\) Pregnant or lactating women;
  • (7\) Patients who are participating in other clinical studies.
  • Note: All patients who meet any one of the above items will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials